Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Operating Income: 2018-2024

Historic Operating Income for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Dec 2024 value amounting to -$95.7 million.

  • Arcturus Therapeutics Holdings' Operating Income fell 53.79% to -$16.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$78.3 million, marking a year-over-year increase of 2.73%. This contributed to the annual value of -$95.7 million for FY2024, which is 22.33% down from last year.
  • According to the latest figures from FY2024, Arcturus Therapeutics Holdings' Operating Income is -$95.7 million, which was down 22.33% from -$78.2 million recorded in FY2023.
  • Arcturus Therapeutics Holdings' 5-year Operating Income high stood at $12.2 million for FY2022, and its period low was -$202.9 million during FY2021.
  • For the 3-year period, Arcturus Therapeutics Holdings' Operating Income averaged around -$53.9 million, with its median value being -$78.2 million (2023).
  • Its Operating Income has fluctuated over the past 5 years, first surged by 106.00% in 2022, then slumped by 742.24% in 2023.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Operating Income (Yearly) stood at -$71.5 million in 2020, then slumped by 183.61% to -$202.9 million in 2021, then skyrocketed by 106.00% to $12.2 million in 2022, then plummeted by 742.24% to -$78.2 million in 2023, then dropped by 22.33% to -$95.7 million in 2024.